NIAID (National Institute of Allergy and Infectious Diseases)
Scientific/Medical
Scientific/Medical Group Awards
HPTN 083 & HPTN 084 Clinical Trial Team
In recognition of exceptional conduct of the HPTN 083 & HPTN 084 clinical trials that resulted in FDA approval of Cabotegravir Long Acting (CAB LA).
NIAID Accelerating COVID-19 Therapeutic Interventions and Vaccines Team
For outstanding efforts to develop and implement the ACTIV-2 trial (Outpatient Monoclonal Antibodies and Other Therapies).
OD (Office of the Director)
Scientific/Medical
Scientific/Medical Group Awards
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Team
For extraordinary work advancing the mission of Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership and efforts to treat COVID-19 and monitor emerging variants.